 Shares of Brainsway NASDAQ:BWAY remained unaffected after the company reported Q2 results.Quarterly Results Earnings per share were up 82.35 over the past year to 0.03, which beat the estimate of 0.13.Revenue of 4,820,000 declined by 15.36 from the same period last year, which beat the estimate of 4,770,000.Guidance Brainsway hasnt issued any earnings guidance for the time being.Revenue guidance hasnt been issued by the company for now.Conference Call Details Date: Aug 12, 2020View more earnings on BWAYTime: 08:30 AMET Webcast URL: Action 52-week high: 12.53Companys 52-week low was at 5.10Price action over last quarter: Up 3.81Company Overview Brainsway Ltd is an Israel based company engaged in the business of developing and providing advanced technology solutions for the treatment of a variety of brain disorders. Its flagship technology is based on Deep Transcranial Magnetic Stimulation TMS which is used for brain disorder treatment such as treatment of depression in patients. The group earns revenues from the sale and lease of devices. It has a business presence in Israel and other foreign countries.See more from Benzinga Earnings Scheduled For August 12, 2020 20 Healthcare Stocks Moving In Thursdays Pre-Market SessionC 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. 